Product Code: RP-ID-10079083 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10079083
Market Overview:
Global Anticoagulant Drugs Industry Overview | By Product (NOACs, Heparin, Warfarin, Others), and Application (Hospital, Pharmacy, Other) - Global Market Opportunity and Current Growth Analysis 2019-2025
Global Molecular Diagnostics Industry was valued at USD 24.6 Billion in the year 2019. Global Molecular Diagnostics Industry is further expected to grow at a CAGR of 5.3% from 2019 to reach USD 32.9 Billion by the year 2025. Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time.
Antithrombotic is a medication that keeps the development of thrombus or clump. Antithrombotic and anticoagulant operators are drugs used to decrease the arrangement of blood clusters by lessening the body's ability to shape a blood coagulation. These medications demonstration by keeping the generation of nutrient K in the liver. Antiplatelet, anticoagulant, and thrombolytic operators are distinctive sorts of antithrombotic specialists that demonstration through various thickening procedures. Blood vessel and venous thrombosis, the two sorts of thrombosis, can be treated with antithrombotic drugs.
The three key reasons for thrombosis are hypercoagulability, anomalous stream of blood, and damage caused to endothelial cells of the vein divider. These causes result from hereditary conditions, idleness, smoking, vein harm, pregnancy, and heftiness. As of now, thrombosis and related issue including myocardial dead tissue, stroke, and pneumonic embolism are essentially treated with off-patent anticoagulant drugs viz. warfarin and heparin. The other type of antithrombotic drugs for example headache medicine is additionally off-patent. With a couple of licensed viable fixes accessible in the market, pharmaceutical organizations have sufficient chances to enhance new items. The new medications could be productive for them, as the expanding total populace would guarantee unfaltering increment in the interest for such life-sparing medications. The worldwide antithrombotic/anticoagulant drugs showcase is relied upon to observe high development amid the conjecture time frame, inferable from elements, for example, high accessibility of these medications and ceaseless conditions related with thrombosis that require long haul tranquilize organization.
Major market players in Anticoagulant Drugs Industry are Bristol-Myers Squibb, Bayer, Pfizer, Johnson & Johnson, Sanofi, Boehringer Ingelheim, Daiichi Sankyo, Novartis AG, GlaxoSmithKline plc, Genentech Inc., AstraZeneca plc, Eli Lilly & Company, Aspen Holdings, Portola Pharmaceuticals Inc. and brief information 6 more companies provided in the report.
Anticoagulant Drugs Industry Segmentation:
Anticoagulant Drugs Industry Overview, By Product
• NOACs
• Heparin
• Warfarin
• Others
Anticoagulant Drugs Industry Overview, By Application
• Hospital
• Pharmacy
• Other
Anticoagulant Drugs Industry Overview, By Region
North America
• USA
• Canada
Europe
• Germany
• U.K.
• France
• Italy
• Rest of Europe
APAC
• China
• India
• Japan
• Rest of Asia-Pacific
RoW
• Latin America
• Middle East & Africa
Related Reports
Proof of Quality & Reliability
